0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Huntington Disease Medications Market Research Report 2024
Published Date: November 2024
|
Report Code: QYRE-Auto-39U18416
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Huntington Disease Medications Market Research Report 2024
BUY CHAPTERS

Global Huntington Disease Medications Market Research Report 2024

Code: QYRE-Auto-39U18416
Report
November 2024
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Huntington Disease Medications Market Size

The global Huntington Disease Medications market was valued at US$ 3040 million in 2023 and is anticipated to reach US$ 8531 million by 2030, witnessing a CAGR of 15.6% during the forecast period 2024-2030.

Huntington Disease Medications Market

Huntington Disease Medications Market

Huntington disease medications are primarily aimed at managing symptoms of this progressive neurodegenerative disorder, as there is currently no cure. Huntington disease affects movement, cognition, and behavior, and medications target these areas to improve patients’ quality of life. Key drugs include tetrabenazine and deutetrabenazine, which reduce involuntary movements (chorea) by decreasing dopamine in the brain.
North American market for Huntington Disease Medications is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Huntington Disease Medications is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Huntington Disease Medications include Bausch Health, Teva, Neurocrine Biosciences, Hetero, Apotex, Actavis Laboratories, Mylan, Bionpharma, Dr. Reddy's Laboratories, Chartwell Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Huntington Disease Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Huntington Disease Medications.
The Huntington Disease Medications market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Huntington Disease Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Huntington Disease Medications manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Huntington Disease Medications Market Report

Report Metric Details
Report Name Huntington Disease Medications Market
Accounted market size in 2023 US$ 3040 million
Forecasted market size in 2030 US$ 8531 million
CAGR 15.6%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
Segment by Application
  • Hospital and Clinic
  • Pharmacy
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bausch Health, Teva, Neurocrine Biosciences, Hetero, Apotex, Actavis Laboratories, Mylan, Bionpharma, Dr. Reddy's Laboratories, Chartwell Pharmaceuticals, Sandoz, Sun Pharmaceutical, Lupin, Zydus
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Huntington Disease Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Huntington Disease Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Huntington Disease Medications Market growing?

Ans: The Huntington Disease Medications Market witnessing a CAGR of 15.6% during the forecast period 2024-2030.

What is the Huntington Disease Medications Market size in 2030?

Ans: The Huntington Disease Medications Market size in 2030 will be US$ 8531 million.

Who are the main players in the Huntington Disease Medications Market report?

Ans: The main players in the Huntington Disease Medications Market are Bausch Health, Teva, Neurocrine Biosciences, Hetero, Apotex, Actavis Laboratories, Mylan, Bionpharma, Dr. Reddy's Laboratories, Chartwell Pharmaceuticals, Sandoz, Sun Pharmaceutical, Lupin, Zydus

What are the Application segmentation covered in the Huntington Disease Medications Market report?

Ans: The Applications covered in the Huntington Disease Medications Market report are Hospital and Clinic, Pharmacy, Other

What are the Type segmentation covered in the Huntington Disease Medications Market report?

Ans: The Types covered in the Huntington Disease Medications Market report are Valbenazine, Deutetrabenazine, Tetrabenazine, Others

Recommended Reports

Neurodegenerative Drugs

Rare Disease Treatments

Genetic and Metabolic Disorders

1 Huntington Disease Medications Market Overview
1.1 Product Definition
1.2 Huntington Disease Medications by Type
1.2.1 Global Huntington Disease Medications Market Value Comparison by Type (2024-2030)
1.2.2 Valbenazine
1.2.3 Deutetrabenazine
1.2.4 Tetrabenazine
1.2.5 Others
1.3 Huntington Disease Medications by Application
1.3.1 Global Huntington Disease Medications Market Value by Application (2024-2030)
1.3.2 Hospital and Clinic
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Huntington Disease Medications Market Size Estimates and Forecasts
1.4.1 Global Huntington Disease Medications Revenue 2019-2030
1.4.2 Global Huntington Disease Medications Sales 2019-2030
1.4.3 Global Huntington Disease Medications Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Huntington Disease Medications Market Competition by Manufacturers
2.1 Global Huntington Disease Medications Sales Market Share by Manufacturers (2019-2024)
2.2 Global Huntington Disease Medications Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Huntington Disease Medications Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Huntington Disease Medications, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Huntington Disease Medications, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Huntington Disease Medications, Product Type & Application
2.7 Global Key Manufacturers of Huntington Disease Medications, Date of Enter into This Industry
2.8 Global Huntington Disease Medications Market Competitive Situation and Trends
2.8.1 Global Huntington Disease Medications Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Huntington Disease Medications Players Market Share by Revenue
2.8.3 Global Huntington Disease Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Huntington Disease Medications Market Scenario by Region
3.1 Global Huntington Disease Medications Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Huntington Disease Medications Sales by Region: 2019-2030
3.2.1 Global Huntington Disease Medications Sales by Region: 2019-2024
3.2.2 Global Huntington Disease Medications Sales by Region: 2025-2030
3.3 Global Huntington Disease Medications Revenue by Region: 2019-2030
3.3.1 Global Huntington Disease Medications Revenue by Region: 2019-2024
3.3.2 Global Huntington Disease Medications Revenue by Region: 2025-2030
3.4 North America Huntington Disease Medications Market Facts & Figures by Country
3.4.1 North America Huntington Disease Medications Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Huntington Disease Medications Sales by Country (2019-2030)
3.4.3 North America Huntington Disease Medications Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Huntington Disease Medications Market Facts & Figures by Country
3.5.1 Europe Huntington Disease Medications Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Huntington Disease Medications Sales by Country (2019-2030)
3.5.3 Europe Huntington Disease Medications Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Huntington Disease Medications Market Facts & Figures by Region
3.6.1 Asia Pacific Huntington Disease Medications Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Huntington Disease Medications Sales by Region (2019-2030)
3.6.3 Asia Pacific Huntington Disease Medications Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Huntington Disease Medications Market Facts & Figures by Country
3.7.1 Latin America Huntington Disease Medications Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Huntington Disease Medications Sales by Country (2019-2030)
3.7.3 Latin America Huntington Disease Medications Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Huntington Disease Medications Market Facts & Figures by Country
3.8.1 Middle East and Africa Huntington Disease Medications Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Huntington Disease Medications Sales by Country (2019-2030)
3.8.3 Middle East and Africa Huntington Disease Medications Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Huntington Disease Medications Sales by Type (2019-2030)
4.1.1 Global Huntington Disease Medications Sales by Type (2019-2024)
4.1.2 Global Huntington Disease Medications Sales by Type (2025-2030)
4.1.3 Global Huntington Disease Medications Sales Market Share by Type (2019-2030)
4.2 Global Huntington Disease Medications Revenue by Type (2019-2030)
4.2.1 Global Huntington Disease Medications Revenue by Type (2019-2024)
4.2.2 Global Huntington Disease Medications Revenue by Type (2025-2030)
4.2.3 Global Huntington Disease Medications Revenue Market Share by Type (2019-2030)
4.3 Global Huntington Disease Medications Price by Type (2019-2030)
5 Segment by Application
5.1 Global Huntington Disease Medications Sales by Application (2019-2030)
5.1.1 Global Huntington Disease Medications Sales by Application (2019-2024)
5.1.2 Global Huntington Disease Medications Sales by Application (2025-2030)
5.1.3 Global Huntington Disease Medications Sales Market Share by Application (2019-2030)
5.2 Global Huntington Disease Medications Revenue by Application (2019-2030)
5.2.1 Global Huntington Disease Medications Revenue by Application (2019-2024)
5.2.2 Global Huntington Disease Medications Revenue by Application (2025-2030)
5.2.3 Global Huntington Disease Medications Revenue Market Share by Application (2019-2030)
5.3 Global Huntington Disease Medications Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bausch Health
6.1.1 Bausch Health Company Information
6.1.2 Bausch Health Description and Business Overview
6.1.3 Bausch Health Huntington Disease Medications Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bausch Health Huntington Disease Medications Product Portfolio
6.1.5 Bausch Health Recent Developments/Updates
6.2 Teva
6.2.1 Teva Company Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Huntington Disease Medications Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Huntington Disease Medications Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Neurocrine Biosciences
6.3.1 Neurocrine Biosciences Company Information
6.3.2 Neurocrine Biosciences Description and Business Overview
6.3.3 Neurocrine Biosciences Huntington Disease Medications Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Neurocrine Biosciences Huntington Disease Medications Product Portfolio
6.3.5 Neurocrine Biosciences Recent Developments/Updates
6.4 Hetero
6.4.1 Hetero Company Information
6.4.2 Hetero Description and Business Overview
6.4.3 Hetero Huntington Disease Medications Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hetero Huntington Disease Medications Product Portfolio
6.4.5 Hetero Recent Developments/Updates
6.5 Apotex
6.5.1 Apotex Company Information
6.5.2 Apotex Description and Business Overview
6.5.3 Apotex Huntington Disease Medications Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Apotex Huntington Disease Medications Product Portfolio
6.5.5 Apotex Recent Developments/Updates
6.6 Actavis Laboratories
6.6.1 Actavis Laboratories Company Information
6.6.2 Actavis Laboratories Description and Business Overview
6.6.3 Actavis Laboratories Huntington Disease Medications Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Actavis Laboratories Huntington Disease Medications Product Portfolio
6.6.5 Actavis Laboratories Recent Developments/Updates
6.7 Mylan
6.7.1 Mylan Company Information
6.7.2 Mylan Description and Business Overview
6.7.3 Mylan Huntington Disease Medications Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Mylan Huntington Disease Medications Product Portfolio
6.7.5 Mylan Recent Developments/Updates
6.8 Bionpharma
6.8.1 Bionpharma Company Information
6.8.2 Bionpharma Description and Business Overview
6.8.3 Bionpharma Huntington Disease Medications Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bionpharma Huntington Disease Medications Product Portfolio
6.8.5 Bionpharma Recent Developments/Updates
6.9 Dr. Reddy's Laboratories
6.9.1 Dr. Reddy's Laboratories Company Information
6.9.2 Dr. Reddy's Laboratories Description and Business Overview
6.9.3 Dr. Reddy's Laboratories Huntington Disease Medications Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Dr. Reddy's Laboratories Huntington Disease Medications Product Portfolio
6.9.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.10 Chartwell Pharmaceuticals
6.10.1 Chartwell Pharmaceuticals Company Information
6.10.2 Chartwell Pharmaceuticals Description and Business Overview
6.10.3 Chartwell Pharmaceuticals Huntington Disease Medications Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Chartwell Pharmaceuticals Huntington Disease Medications Product Portfolio
6.10.5 Chartwell Pharmaceuticals Recent Developments/Updates
6.11 Sandoz
6.11.1 Sandoz Company Information
6.11.2 Sandoz Description and Business Overview
6.11.3 Sandoz Huntington Disease Medications Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sandoz Huntington Disease Medications Product Portfolio
6.11.5 Sandoz Recent Developments/Updates
6.12 Sun Pharmaceutical
6.12.1 Sun Pharmaceutical Company Information
6.12.2 Sun Pharmaceutical Description and Business Overview
6.12.3 Sun Pharmaceutical Huntington Disease Medications Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Sun Pharmaceutical Huntington Disease Medications Product Portfolio
6.12.5 Sun Pharmaceutical Recent Developments/Updates
6.13 Lupin
6.13.1 Lupin Company Information
6.13.2 Lupin Description and Business Overview
6.13.3 Lupin Huntington Disease Medications Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Lupin Huntington Disease Medications Product Portfolio
6.13.5 Lupin Recent Developments/Updates
6.14 Zydus
6.14.1 Zydus Company Information
6.14.2 Zydus Description and Business Overview
6.14.3 Zydus Huntington Disease Medications Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Zydus Huntington Disease Medications Product Portfolio
6.14.5 Zydus Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Huntington Disease Medications Industry Chain Analysis
7.2 Huntington Disease Medications Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Huntington Disease Medications Production Mode & Process
7.4 Huntington Disease Medications Sales and Marketing
7.4.1 Huntington Disease Medications Sales Channels
7.4.2 Huntington Disease Medications Distributors
7.5 Huntington Disease Medications Customers
8 Huntington Disease Medications Market Dynamics
8.1 Huntington Disease Medications Industry Trends
8.2 Huntington Disease Medications Market Drivers
8.3 Huntington Disease Medications Market Challenges
8.4 Huntington Disease Medications Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Huntington Disease Medications Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Huntington Disease Medications Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Huntington Disease Medications Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Huntington Disease Medications Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Huntington Disease Medications Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Huntington Disease Medications Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Huntington Disease Medications Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Huntington Disease Medications Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Huntington Disease Medications, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Huntington Disease Medications, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Huntington Disease Medications, Product Type & Application
 Table 12. Global Key Manufacturers of Huntington Disease Medications, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Huntington Disease Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Huntington Disease Medications as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Huntington Disease Medications Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Huntington Disease Medications Sales by Region (2019-2024) & (K Units)
 Table 18. Global Huntington Disease Medications Sales Market Share by Region (2019-2024)
 Table 19. Global Huntington Disease Medications Sales by Region (2025-2030) & (K Units)
 Table 20. Global Huntington Disease Medications Sales Market Share by Region (2025-2030)
 Table 21. Global Huntington Disease Medications Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Huntington Disease Medications Revenue Market Share by Region (2019-2024)
 Table 23. Global Huntington Disease Medications Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Huntington Disease Medications Revenue Market Share by Region (2025-2030)
 Table 25. North America Huntington Disease Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Huntington Disease Medications Sales by Country (2019-2024) & (K Units)
 Table 27. North America Huntington Disease Medications Sales by Country (2025-2030) & (K Units)
 Table 28. North America Huntington Disease Medications Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Huntington Disease Medications Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Huntington Disease Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Huntington Disease Medications Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Huntington Disease Medications Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Huntington Disease Medications Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Huntington Disease Medications Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Huntington Disease Medications Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Huntington Disease Medications Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Huntington Disease Medications Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Huntington Disease Medications Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Huntington Disease Medications Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Huntington Disease Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Huntington Disease Medications Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Huntington Disease Medications Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Huntington Disease Medications Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Huntington Disease Medications Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Huntington Disease Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Huntington Disease Medications Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Huntington Disease Medications Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Huntington Disease Medications Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Huntington Disease Medications Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Huntington Disease Medications Sales (K Units) by Type (2019-2024)
 Table 51. Global Huntington Disease Medications Sales (K Units) by Type (2025-2030)
 Table 52. Global Huntington Disease Medications Sales Market Share by Type (2019-2024)
 Table 53. Global Huntington Disease Medications Sales Market Share by Type (2025-2030)
 Table 54. Global Huntington Disease Medications Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Huntington Disease Medications Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Huntington Disease Medications Revenue Market Share by Type (2019-2024)
 Table 57. Global Huntington Disease Medications Revenue Market Share by Type (2025-2030)
 Table 58. Global Huntington Disease Medications Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Huntington Disease Medications Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Huntington Disease Medications Sales (K Units) by Application (2019-2024)
 Table 61. Global Huntington Disease Medications Sales (K Units) by Application (2025-2030)
 Table 62. Global Huntington Disease Medications Sales Market Share by Application (2019-2024)
 Table 63. Global Huntington Disease Medications Sales Market Share by Application (2025-2030)
 Table 64. Global Huntington Disease Medications Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Huntington Disease Medications Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Huntington Disease Medications Revenue Market Share by Application (2019-2024)
 Table 67. Global Huntington Disease Medications Revenue Market Share by Application (2025-2030)
 Table 68. Global Huntington Disease Medications Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Huntington Disease Medications Price (US$/Unit) by Application (2025-2030)
 Table 70. Bausch Health Company Information
 Table 71. Bausch Health Description and Business Overview
 Table 72. Bausch Health Huntington Disease Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Bausch Health Huntington Disease Medications Product
 Table 74. Bausch Health Recent Developments/Updates
 Table 75. Teva Company Information
 Table 76. Teva Description and Business Overview
 Table 77. Teva Huntington Disease Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Teva Huntington Disease Medications Product
 Table 79. Teva Recent Developments/Updates
 Table 80. Neurocrine Biosciences Company Information
 Table 81. Neurocrine Biosciences Description and Business Overview
 Table 82. Neurocrine Biosciences Huntington Disease Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Neurocrine Biosciences Huntington Disease Medications Product
 Table 84. Neurocrine Biosciences Recent Developments/Updates
 Table 85. Hetero Company Information
 Table 86. Hetero Description and Business Overview
 Table 87. Hetero Huntington Disease Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Hetero Huntington Disease Medications Product
 Table 89. Hetero Recent Developments/Updates
 Table 90. Apotex Company Information
 Table 91. Apotex Description and Business Overview
 Table 92. Apotex Huntington Disease Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Apotex Huntington Disease Medications Product
 Table 94. Apotex Recent Developments/Updates
 Table 95. Actavis Laboratories Company Information
 Table 96. Actavis Laboratories Description and Business Overview
 Table 97. Actavis Laboratories Huntington Disease Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Actavis Laboratories Huntington Disease Medications Product
 Table 99. Actavis Laboratories Recent Developments/Updates
 Table 100. Mylan Company Information
 Table 101. Mylan Description and Business Overview
 Table 102. Mylan Huntington Disease Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Mylan Huntington Disease Medications Product
 Table 104. Mylan Recent Developments/Updates
 Table 105. Bionpharma Company Information
 Table 106. Bionpharma Description and Business Overview
 Table 107. Bionpharma Huntington Disease Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Bionpharma Huntington Disease Medications Product
 Table 109. Bionpharma Recent Developments/Updates
 Table 110. Dr. Reddy's Laboratories Company Information
 Table 111. Dr. Reddy's Laboratories Description and Business Overview
 Table 112. Dr. Reddy's Laboratories Huntington Disease Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Dr. Reddy's Laboratories Huntington Disease Medications Product
 Table 114. Dr. Reddy's Laboratories Recent Developments/Updates
 Table 115. Chartwell Pharmaceuticals Company Information
 Table 116. Chartwell Pharmaceuticals Description and Business Overview
 Table 117. Chartwell Pharmaceuticals Huntington Disease Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Chartwell Pharmaceuticals Huntington Disease Medications Product
 Table 119. Chartwell Pharmaceuticals Recent Developments/Updates
 Table 120. Sandoz Company Information
 Table 121. Sandoz Description and Business Overview
 Table 122. Sandoz Huntington Disease Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Sandoz Huntington Disease Medications Product
 Table 124. Sandoz Recent Developments/Updates
 Table 125. Sun Pharmaceutical Company Information
 Table 126. Sun Pharmaceutical Description and Business Overview
 Table 127. Sun Pharmaceutical Huntington Disease Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Sun Pharmaceutical Huntington Disease Medications Product
 Table 129. Sun Pharmaceutical Recent Developments/Updates
 Table 130. Lupin Company Information
 Table 131. Lupin Description and Business Overview
 Table 132. Lupin Huntington Disease Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. Lupin Huntington Disease Medications Product
 Table 134. Lupin Recent Developments/Updates
 Table 135. Zydus Company Information
 Table 136. Zydus Description and Business Overview
 Table 137. Zydus Huntington Disease Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 138. Zydus Huntington Disease Medications Product
 Table 139. Zydus Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Huntington Disease Medications Distributors List
 Table 143. Huntington Disease Medications Customers List
 Table 144. Huntington Disease Medications Market Trends
 Table 145. Huntington Disease Medications Market Drivers
 Table 146. Huntington Disease Medications Market Challenges
 Table 147. Huntington Disease Medications Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Huntington Disease Medications
 Figure 2. Global Huntington Disease Medications Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Huntington Disease Medications Market Share by Type: 2023 & 2030
 Figure 4. Valbenazine Product Picture
 Figure 5. Deutetrabenazine Product Picture
 Figure 6. Tetrabenazine Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Huntington Disease Medications Market Value by Application (2024-2030) & (US$ Million)
 Figure 9. Global Huntington Disease Medications Market Share by Application: 2023 & 2030
 Figure 10. Hospital and Clinic
 Figure 11. Pharmacy
 Figure 12. Other
 Figure 13. Global Huntington Disease Medications Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global Huntington Disease Medications Market Size (2019-2030) & (US$ Million)
 Figure 15. Global Huntington Disease Medications Sales (2019-2030) & (K Units)
 Figure 16. Global Huntington Disease Medications Average Price (US$/Unit) & (2019-2030)
 Figure 17. Huntington Disease Medications Report Years Considered
 Figure 18. Huntington Disease Medications Sales Share by Manufacturers in 2023
 Figure 19. Global Huntington Disease Medications Revenue Share by Manufacturers in 2023
 Figure 20. Global 5 and 10 Largest Huntington Disease Medications Players: Market Share by Revenue in Huntington Disease Medications in 2023
 Figure 21. Huntington Disease Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 22. Global Huntington Disease Medications Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 23. North America Huntington Disease Medications Sales Market Share by Country (2019-2030)
 Figure 24. North America Huntington Disease Medications Revenue Market Share by Country (2019-2030)
 Figure 25. United States Huntington Disease Medications Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Canada Huntington Disease Medications Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Europe Huntington Disease Medications Sales Market Share by Country (2019-2030)
 Figure 28. Europe Huntington Disease Medications Revenue Market Share by Country (2019-2030)
 Figure 29. Germany Huntington Disease Medications Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. France Huntington Disease Medications Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. U.K. Huntington Disease Medications Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Italy Huntington Disease Medications Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Russia Huntington Disease Medications Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Asia Pacific Huntington Disease Medications Sales Market Share by Region (2019-2030)
 Figure 35. Asia Pacific Huntington Disease Medications Revenue Market Share by Region (2019-2030)
 Figure 36. China Huntington Disease Medications Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Japan Huntington Disease Medications Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. South Korea Huntington Disease Medications Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. India Huntington Disease Medications Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Australia Huntington Disease Medications Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. China Taiwan Huntington Disease Medications Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Southeast Asia Huntington Disease Medications Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Latin America Huntington Disease Medications Sales Market Share by Country (2019-2030)
 Figure 44. Mexico Huntington Disease Medications Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Brazil Huntington Disease Medications Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Argentina Huntington Disease Medications Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Colombia Huntington Disease Medications Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Middle East and Africa Huntington Disease Medications Sales Market Share by Country (2019-2030)
 Figure 49. Middle East and Africa Huntington Disease Medications Revenue Market Share by Country (2019-2030)
 Figure 50. Turkey Huntington Disease Medications Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Saudi Arabia Huntington Disease Medications Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. UAE Huntington Disease Medications Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Global Sales Market Share of Huntington Disease Medications by Type (2019-2030)
 Figure 54. Global Revenue Market Share of Huntington Disease Medications by Type (2019-2030)
 Figure 55. Global Huntington Disease Medications Price (US$/Unit) by Type (2019-2030)
 Figure 56. Global Sales Market Share of Huntington Disease Medications by Application (2019-2030)
 Figure 57. Global Revenue Market Share of Huntington Disease Medications by Application (2019-2030)
 Figure 58. Global Huntington Disease Medications Price (US$/Unit) by Application (2019-2030)
 Figure 59. Huntington Disease Medications Value Chain
 Figure 60. Huntington Disease Medications Production Process
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS